Aylo Freesites Ltd et al. v. DISH Technologies L.L.C. et al.

Apple Inc.vsTelcom Ventures LLC

Apple has filed an IPR petition seeking cancellation of all 14 claims of Telcom Ventures’ ’743 patent, asserting that the claims are obvious over a combination of prior‑art references covering NFC‑based mobile payments.

Apple Inc.vsHBCU Messaging US LP

Wilus seeks director review to overturn the PTAB’s institution of Samsung’s IPR on Wi‑Fi patents, arguing settled expectations and inconsistent indefiniteness positions.

Ewald Dorken AGvsSchaeffler Technologies AG & Co. KG et al.

Ewald Dörken AG has filed an IPR petition seeking to invalidate claims 1‑7 of Schaeffler’s wheel‑bearing coating patent, alleging obviousness over six prior‑art references and indefiniteness of key claim terms.

Altice USA, Inc. et al.vsTouchstream Technologies, Inc.

Altice USA filed a petition challenging claims of Touchstream Technologies' patent via an IPR proceeding focused on obviousness (103). The petitioner argues that Claims 1-20 are rendered obvious by combining prior art references such as Aldrey and Mahajan. This petition was subsequently joined into an already instituted IPR, continuing the dispute over media content control technology.

Merck Sharp & Dohme LLC et al.vsThe Johns Hopkins University

Merck Sharp & Dohme LLC challenged U.S. Patent No. 11,643,462 in the PTAB, arguing that all claims are anticipated under 35 U.S.C. § 102 and rendered obvious under 35 U.S.C. § 103. The petitioner asserts that the MSI-H Study Record discloses the claimed method of treating MSI-H cancer with pembrolizumab, leading to a request for institution based on compelling evidence.